Clinical Trials Logo

Clinical Trial Summary

In this trial, Respiratory Motion Guided (RMG) 4DCBCT will be implemented for the first time on lung cancer patients. RMG-4DCBCT adapts the image acquisition as the patient's breathing changes (i.e. if the patient breathes faster, imaging data is acquired faster). By adapting the acquisition to the dynamic patient, personalised images of a patients lungs are able to be acquired for radiotherapy treatments.


Clinical Trial Description

Four dimensional cone beam computed tomography (4DCBCT) continues to play a pivotal role in the safe delivery of radiotherapy treatments for lung cancer patients. 4DCBCT meets exacting tumour localisation requirements by allowing radiation therapists to measure the tumour as a patient breathes (4D=volumetric images plus respiratory induced tumour motion). Despite the success of 4DCBCT to date, it suffers from relatively poor image quality, very long scan times (4min) and higher imaging doses than are necessary. The primary reason for these problems is that although the purpose of 4DCBCT is to acquire information about tumour motion due to respiration, there is no feedback from the patients breathing signal to adapt and optimise the image acquisition process. This clinical trial is a phase 1 first in human's pilot study and the aim is therefore to prove feasibility of RMG-4DCBCT, not necessarily efficacy. As such, patient scans will be acquired across a broad range of patient breathing conditions to optimise the RMG-4DCBCT technique and also to plan a hypothesis driven clinical trial to follow. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04070586
Study type Observational
Source University of Sydney
Contact
Status Completed
Phase
Start date August 21, 2019
Completion date February 19, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT06152419 - Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project N/A
Recruiting NCT04105647 - Lifestyle Modification Program for Lung Cancer Patients - A Pilot Study N/A
Completed NCT05732350 - Exploratory Drug Interaction Study Between SMIs and DOACs
Active, not recruiting NCT04300244 - Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma Phase 2
Recruiting NCT05311709 - Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities Phase 2
Active, not recruiting NCT04396457 - Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901 Phase 2
Not yet recruiting NCT03910283 - Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer N/A
Recruiting NCT03301493 - Genomic Testing and Resulting Medical Decisions
Completed NCT04788147 - Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X) N/A
Not yet recruiting NCT06035731 - Evaluation of the Medical Service by Socio-aesthetics in Oncology N/A
Recruiting NCT03274349 - Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial Carcinoma N/A
Recruiting NCT05830097 - A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT02991677 - Exercise Effect on Chemotherapy-Induced Neuropathic Pain N/A
Completed NCT04971304 - Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
Recruiting NCT04859400 - Influence of a Home-based Nutrition and Exercise Program on Quality of Life of Palliative Cancer Outpatients N/A
Recruiting NCT05948865 - A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors Phase 1
Recruiting NCT04270890 - Investigation of an Abdominal Compression Device N/A
Not yet recruiting NCT05154474 - Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
Not yet recruiting NCT05857995 - Precision Lung Cancer Survivorship Care Intervention N/A
Not yet recruiting NCT03622528 - Quantitative Lung Cancer Screening